Security key
92511W108
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 30,028,982
- Total 13F value
- $21,000,938
- Share change
- +14,694,365
- Put/Call ratio
- 222%
- SEC-reported price per share
- $0.70
- Number of holders
- 79
- Value change
- +$9,292,302
- Number of buys
- 38
- Number of sells
- 34
- Shares outstanding
- 92,448,158
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
79
Top holders
10
VRCA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W108
Recent filing periods:
Ownership snapshot
Top reported holders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Caligan Partners LP
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
3/4/5
13F
Lead comparable stake: 10%
13D/G row: Caligan Partners LP
Showing 1-6 of 15 holder rows.
Quick read
Caligan Partners LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Caligan Partners LP's linked filing trail.
Comparable ownership
Top 5
Caligan Partners LP
10%
PERCEPTIVE ADVISORS LLC
7.7%
VANGUARD GROUP INC
1.4%
BlackRock, Inc.
1.2%
FMR LLC
0.69%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Caligan Partners LP |
13D/G
|
10%
|
$7,769,760
15,856,653 shares
|
$0 | 31 Dec 2024 |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
7.7%
from 13F
|
$51,398,078
7,099,182 shares
|
— | 27 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1.4%
|
$1,865,570
1,286,600 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
1.2%
|
$1,573,887
1,085,439 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
0.69%
|
$919,749
634,310 shares
|
— | 30 Sep 2024 |
| STATE STREET CORP |
13F
Company
|
0.55%
|
$743,590
512,821 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
79
Shares
30,028,982
Rows available
79
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q4 2024 holders
79
Holder diff
78
| Investor | Q3 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend